Published in N Engl J Med on July 10, 1986
Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev (1997) 12.33
Fluoroquinolone antimicrobial agents. Clin Microbiol Rev (1989) 6.45
Antimicrobial resistance: the example of Staphylococcus aureus. J Clin Invest (2003) 5.33
Guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis (2011) 4.09
Natural population dynamics and expansion of pathogenic clones of Staphylococcus aureus. J Clin Invest (2004) 2.86
Comparison of multilocus sequence typing and pulsed-field gel electrophoresis as tools for typing Staphylococcus aureus isolates in a microepidemiological setting. J Clin Microbiol (2002) 2.45
Hospital epidemiology and infection control in acute-care settings. Clin Microbiol Rev (2011) 2.22
Phenotypic and genotypic characterization of nosocomial Staphylococcus aureus isolates from trauma patients. J Clin Microbiol (1998) 2.22
Determinants of acquisition and carriage of Staphylococcus aureus in infancy. J Clin Microbiol (2003) 1.87
Measuring quality of life in clinical trials: a taxonomy and review. CMAJ (1989) 1.73
Laboratory and clinical evaluation of conjugate vaccines composed of Staphylococcus aureus type 5 and type 8 capsular polysaccharides bound to Pseudomonas aeruginosa recombinant exoprotein A. Infect Immun (1993) 1.70
Mupirocin-based decolonization of Staphylococcus aureus carriers in residents of 2 long-term care facilities: a randomized, double-blind, placebo-controlled trial. Clin Infect Dis (2003) 1.69
Synthesis and immunologic properties in mice of vaccines composed of Staphylococcus aureus type 5 and type 8 capsular polysaccharides conjugated to Pseudomonas aeruginosa exotoxin A. Infect Immun (1990) 1.69
Surface proteins that promote adherence of Staphylococcus aureus to human desquamated nasal epithelial cells. BMC Microbiol (2009) 1.68
Discontinuation of contact precautions for methicillin-resistant staphylococcus aureus: a randomized controlled trial comparing passive and active screening with culture and polymerase chain reaction. Clin Infect Dis (2013) 1.57
Staphylococcus aureus binding to human nasal mucin. Infect Immun (1996) 1.50
Lysostaphin cream eradicates Staphylococcus aureus nasal colonization in a cotton rat model. Antimicrob Agents Chemother (2003) 1.48
Immunoblots, antimicrobial resistance, and bacteriophage typing of oxacillin-resistant Staphylococcus aureus. J Clin Microbiol (1988) 1.44
Nasal decolonization of Staphylococcus aureus with mupirocin: strengths, weaknesses and future prospects. J Antimicrob Chemother (2009) 1.35
c-di-GMP (3'-5'-cyclic diguanylic acid) inhibits Staphylococcus aureus cell-cell interactions and biofilm formation. Antimicrob Agents Chemother (2005) 1.32
Targeted intranasal mupirocin to prevent colonization and infection by community-associated methicillin-resistant Staphylococcus aureus strains in soldiers: a cluster randomized controlled trial. Antimicrob Agents Chemother (2007) 1.30
Randomized double-blinded trial of rifampin with either novobiocin or trimethoprim-sulfamethoxazole against methicillin-resistant Staphylococcus aureus colonization: prevention of antimicrobial resistance and effect of host factors on outcome. Antimicrob Agents Chemother (1993) 1.26
Abscess formation and alpha-hemolysin induced toxicity in a mouse model of Staphylococcus aureus peritoneal infection. Infect Immun (2012) 1.16
Improved understanding of factors driving methicillin-resistant Staphylococcus aureus epidemic waves. Clin Epidemiol (2013) 1.15
Iron-regulated surface determinant protein A mediates adhesion of Staphylococcus aureus to human corneocyte envelope proteins. Infect Immun (2009) 1.09
Staphylococcus aureus nasal carriage as a marker for subsequent staphylococcal infections in intensive care unit patients. Eur J Clin Microbiol Infect Dis (1997) 1.08
Safety and immunogenicity of a novel Staphylococcus aureus vaccine: results from the first study of the vaccine dose range in humans. Clin Vaccine Immunol (2010) 1.07
Comparative immunogenicity of conjugates composed of the Staphylococcus aureus type 8 capsular polysaccharide bound to carrier proteins by adipic acid dihydrazide or N-succinimidyl-3-(2-pyridyldithio)propionate. Infect Immun (1992) 1.07
A trial of discontinuation of empiric vancomycin therapy in patients with suspected methicillin-resistant Staphylococcus aureus health care-associated pneumonia. Antimicrob Agents Chemother (2012) 1.02
Emergence and persistence of macrolide resistance in oropharyngeal flora and elimination of nasal carriage of Staphylococcus aureus after therapy with slow-release clarithromycin: a randomized, double-blind, placebo-controlled study. Antimicrob Agents Chemother (2004) 1.01
IsdA protects Staphylococcus aureus against the bactericidal protease activity of apolactoferrin. Infect Immun (2008) 1.00
Prospective study of microbial colonization of the nose and skin and infection of the vascular access site in hemodialysis patients. J Clin Microbiol (1988) 0.95
Staphylococcus aureus colonization and infection in patients on continuous ambulatory peritoneal dialysis. J Clin Microbiol (1990) 0.91
The effects of spatial structure, frequency dependence and resistance evolution on the dynamics of toxin-mediated microbial invasions. Evol Appl (2015) 0.83
The potential economic value of a Staphylococcus aureus vaccine among hemodialysis patients. Vaccine (2012) 0.82
Cloning, expression, purification, crystallization and preliminary X-ray diffraction studies of N-acetylneuraminate lyase from methicillin-resistant Staphylococcus aureus. Acta Crystallogr Sect F Struct Biol Cryst Commun (2013) 0.80
Catheter-related bloodstream infections. Semin Intervent Radiol (2009) 0.80
Staphylococcus aureus septic arthritis in patients on hemodialysis treatment. West J Med (1995) 0.80
Risk and Prognosis of Bloodstream Infections among Patients on Chronic Hemodialysis: A Population-Based Cohort Study. PLoS One (2015) 0.80
Factors associated with Staphylococcus aureus nasal carriage and molecular characteristics among the general population at a Medical College Campus in Guangzhou, South China. Ann Clin Microbiol Antimicrob (2017) 0.80
Infectious and catheter-related complications in pediatric patients treated with peritoneal dialysis at a single institution. Pediatr Nephrol (1995) 0.79
Staphylococcus aureus Colonization and Nosocomial Infections: Implications for Prevention. Curr Infect Dis Rep (2004) 0.78
Antibiotic sensitivity pattern of Staphylococcus aureus from clinical isolates in a tertiary health institution in Kano, Northwestern Nigeria. Pan Afr Med J (2011) 0.78
Comparison of the bacterial flora of the nasal vestibule and cavity in haemodialysis patients. Acta Otorhinolaryngol Ital (2009) 0.78
The Dynamic of Staphylococcus aureus Nasal Carriage in Central Iran. Jundishapur J Microbiol (2015) 0.77
Eradication of methicillin-resistant Staphylococcus aureus from the lower respiratory tract of patients with cystic fibrosis. Can J Infect Dis (1995) 0.77
Cross-contamination: Comparison of Nasal and Chronic Leg Ulcer Staphylococcus aureus Strains Isolated from the Same Patient. Open Microbiol J (2013) 0.76
Concordance of PCR and culture from nasal swabs for detection of methicillin-resistant Staphylococcus aureus in a setting of concurrent antistaphylococcal antibiotics. J Clin Microbiol (2014) 0.76
Ciprofloxacin-resistant methicillin-resistant Staphylococcus aureus in New York health care facilities, 1988. The New York MRSA Study Group. Am J Public Health (1990) 0.76
Staphylococcus aureus nasal carriage in hemodialysis centers of Fez, Morocco. Iran J Microbiol (2014) 0.75
Medical complications in hemodialysis patients requiring vascular access radiology procedures. Semin Intervent Radiol (2004) 0.75
Methicillin-resistant Staphylococcus aureus (MRSA) nasal real-time PCR: a predictive tool for contamination of the hospital environment. Infect Control Hosp Epidemiol (2015) 0.75
Increased risk of bacteremia in patients hemodialyzed through central catheters. Can J Infect Dis (1990) 0.75
Clinical Risk Factors for Infective Endocarditis in Staphylococcus aureus Bacteremia. Tex Heart Inst J (2017) 0.75
Selective staphylococcal broth. J Clin Microbiol (1990) 0.75
API system: a multitube micromethod for identification of Enterobacteriaceae. Appl Microbiol (1972) 15.29
Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med (2001) 9.08
The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance. Am J Med (1996) 6.49
Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy. Ann Intern Med (1991) 5.85
Multi-laboratory evaluation of an automated microbial detection/identification system. J Clin Microbiol (1978) 5.74
Methicillin-resistant Staphylococcus aureus: a consensus review of the microbiology, pathogenesis, and epidemiology with implications for prevention and management. Am J Med (1993) 4.72
Collaborative investigation of the AutoMicrobic System Enterobacteriaceae biochemical card. J Clin Microbiol (1980) 4.28
New system for cultivation of Neisseria gonorrhoeae. Appl Microbiol (1974) 4.27
Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum beta-lactamase production in Klebsiella pneumoniae isolates causing bacteremia. Clin Infect Dis (2000) 4.24
Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription. Am J Respir Crit Care Med (2000) 4.21
Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory. J Clin Microbiol (2001) 4.19
Legionellosis. N Engl J Med (1997) 4.12
New and emerging etiologies for community-acquired pneumonia with implications for therapy. A prospective multicenter study of 359 cases. Medicine (Baltimore) (1990) 4.04
Antibiotic therapy for Pseudomonas aeruginosa bacteremia: outcome correlations in a prospective study of 200 patients. Am J Med (1989) 3.98
Is pneumonia really the old man's friend? Two-year prognosis after community-acquired pneumonia. Lancet (1993) 3.89
Determinants of compliance with antiretroviral therapy in patients with human immunodeficiency virus: prospective assessment with implications for enhancing compliance. AIDS Care (1996) 3.70
Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. American Thoracic Society. Medical Section of the American Lung Association. Am Rev Respir Dis (1993) 3.68
National character does not reflect mean personality trait levels in 49 cultures. Science (2005) 3.56
Ubiquitousness of Legionella pneumophila in the water supply of a hospital with endemic Legionnaires' disease. N Engl J Med (1982) 3.25
Evaluation of the pathotec Rapid I-D system for identification of Enterobacteriaceae. J Clin Microbiol (1975) 3.20
Evaluation of the Rapid Strep system for the identification of clinical isolates of Streptococcus species. J Clin Microbiol (1984) 3.16
Improved medium for detecting deoxyribonuclease-producing bacteria. Appl Microbiol (1969) 3.14
Serratia marcescens: historical perspective and clinical review. N Engl J Med (1979) 3.08
Methicillin-resistant staphylococcal colonization and infection in a long-term care facility. Ann Intern Med (1991) 3.04
Isolation of Legionella pneumophila from hospital shower heads. Ann Intern Med (1981) 2.89
Enterococcal superinfection and colonization after therapy with moxalactam, a new broad-spectrum antibiotic. Ann Intern Med (1981) 2.80
Combination antibiotic therapy versus monotherapy for gram-negative bacteraemia: a commentary. Int J Antimicrob Agents (1999) 2.64
Do in vitro susceptibility data predict the microbiologic response to amphotericin B? Results of a prospective study of patients with Candida fungemia. J Infect Dis (1998) 2.61
Evaluation of the modified Micro-ID system for identification of Enterobacteriaceae. J Clin Microbiol (1979) 2.61
R-B enteric differential system for identification of Enterobacteriaceae. Appl Microbiol (1971) 2.47
Nature over nurture: temperament, personality, and life span development. J Pers Soc Psychol (2000) 2.38
Disease due to the Legionellaceae (other than Legionella pneumophila). Historical, microbiological, clinical, and epidemiological review. Medicine (Baltimore) (1989) 2.31
Evaluation of housestaff physicians' preparation and interpretation of sputum Gram stains for community-acquired pneumonia. J Gen Intern Med (1991) 2.28
Roseomonas, a new genus associated with bacteremia and other human infections. J Clin Microbiol (1993) 2.28
Infections caused by Pseudomonas maltophilia with emphasis on bacteremia: case reports and a review of the literature. Rev Infect Dis (1983) 2.27
Diagnosis of Legionnaires' disease. An update of laboratory methods with new emphasis on isolation by culture. JAMA (1983) 2.14
Therapeutic approaches in patients with candidemia. Evaluation in a multicenter, prospective, observational study. Arch Intern Med (1996) 2.09
Mode of transmission of Legionella pneumophila. A critical review. Arch Intern Med (1986) 2.04
Molecular cloning and pro-apoptotic activity of ICErelII and ICErelIII, members of the ICE/CED-3 family of cysteine proteases. J Biol Chem (1995) 2.02
Evaluation of the redesigned enterotube--a system for the identification of Enterobacteriaceae. Appl Microbiol (1973) 1.98
The gram positive cocci. Hum Pathol (1976) 1.90
Association with prior fluoroquinolone therapy of widespread ciprofloxacin resistance among gram-negative isolates in a Veterans Affairs medical center. Antimicrob Agents Chemother (1991) 1.87
Association of serotypes of Streptococcus pneumoniae with disease severity and outcome in adults: an international study. Clin Infect Dis (2007) 1.87
Osteomyelitis due to Veillonella parvula: case report and review. Clin Infect Dis (1992) 1.86
Susceptibility of Pseudomonas maltophilia to antimicrobial agents, singly and in combination. Antimicrob Agents Chemother (1979) 1.86
Antimicrobial resistance and clinical outcome of Bacteroides bacteremia: findings of a multicenter prospective observational trial. Clin Infect Dis (2000) 1.83
Ecology of Legionella pneumophila within water distribution systems. Appl Environ Microbiol (1985) 1.83
Significance of isolation of Aspergillus from the respiratory tract in diagnosis of invasive pulmonary aspergillosis. Results from a three-year prospective study. Am J Med (1986) 1.81
Comparison of molecular methods for subtyping patients and epidemiologically linked environmental isolates of Legionella pneumophila. J Infect Dis (1988) 1.80
Epidemiologic perspectives on Enterobacter for the infection control professional. Am J Infect Control (1994) 1.78
In vitro evaluation of combination of fluconazole and flucytosine against Cryptococcus neoformans var. neoformans. Antimicrob Agents Chemother (1995) 1.77
A pink-pigmented, oxidative, nonmotile bacterium as a cause of opportunistic infections. Arch Intern Med (1989) 1.73
autoSCAN-4 system for identification of gram-negative bacilli. J Clin Microbiol (1985) 1.73
Accuracy and precision of the autobac system for rapid identification of Gram-negative bacilli: a collaborative evaluation. J Clin Microbiol (1982) 1.68
Early and late onset sepsis in very-low-birth-weight infants from a large group of neonatal intensive care units. Early Hum Dev (2012) 1.64
Comparative susceptibilities of Pseudomonas aeruginosa to 1-oxacephalosporin (LY 127935) and eight other antipseudomonal antimicrobial agents (old and new). Antimicrob Agents Chemother (1980) 1.62
Long-term morbidities associated with vocal cord paralysis after surgical closure of a patent ductus arteriosus in extremely low birth weight infants. J Perinatol (2009) 1.60
Trimethoprim-sulfamethoxazole for the prevention of spontaneous bacterial peritonitis in cirrhosis: a randomized trial. Ann Intern Med (1995) 1.59
High-dose acyclovir compared with short-course preemptive ganciclovir therapy to prevent cytomegalovirus disease in liver transplant recipients. A randomized trial. Ann Intern Med (1994) 1.59
Antimicrobial selection by a computer. A blinded evaluation by infectious diseases experts. JAMA (1979) 1.56
Manual of culture methodology for Legionella. Semin Respir Infect (1987) 1.54
In-use evaluation of a commercially available set of quality control cultures. Appl Microbiol (1973) 1.54
Extended-spectrum beta-lactamases: a call for improved detection and control. Clin Infect Dis (1999) 1.53
Infections caused by Pseudomonas maltophilia. Expanding clinical spectrum. Arch Intern Med (1987) 1.53
Evaluation of the improved Auxotab 1 System for identifying Enterobacteriaceae. Appl Microbiol (1973) 1.50
Efficacy of oral ciprofloxacin plus rifampin for treatment of malignant external otitis. Arch Otolaryngol Head Neck Surg (1989) 1.50
Auxotab--a device for identifying enteric bacteria. Appl Microbiol (1973) 1.50
Erythromycin ototoxicity: prospective assessment with serum concentrations and audiograms in a study of patients with pneumonia. Am J Med (1992) 1.46
Beta-Lactam antibiotic-induced leukopenia in severe hepatic dysfunction: risk factors and implications for dosing in patients with liver disease. Am J Med (1993) 1.46
Immunoblots, antimicrobial resistance, and bacteriophage typing of oxacillin-resistant Staphylococcus aureus. J Clin Microbiol (1988) 1.44
Listeria monocytogenes peritonitis in cirrhotic patients. Value of ascitic fluid gram stain and a review of literature. Dig Dis Sci (1994) 1.43
Potable water as a cause of sporadic cases of community-acquired legionnaires' disease. N Engl J Med (1992) 1.43
Medium containing trypan blue and antibiotics for the detection of Cryptococcus neoformans in clinical samples. Appl Microbiol (1974) 1.41
Role of aerobic gram-negative rods, anaerobes, and fungi in wound infection after head and neck surgery: implications for antibiotic prophylaxis. Head Neck (1989) 1.41
Protecting tomorrow's health care professionals against hepatitis B virus today. Arch Intern Med (1991) 1.40
Analysis of trends in antimicrobial resistance patterns among clinical isolates of Bacteroides fragilis group species from 1990 to 1994. Clin Infect Dis (1996) 1.38
Measuring second-order selection bias in a work site health program. J Occup Med (1994) 1.38
Impediments to clinical research in the United States. Clin Pharmacol Ther (2012) 1.36
Isolation of Pittsburgh pneumonia agent from nebulizers used in respiratory therapy. Ann Intern Med (1980) 1.36
Clinical demonstration of isolation of Nocardia asteroides on buffered charcoal-yeast extract media. J Clin Microbiol (1992) 1.36
Legionnaires' disease: new clinical perspective from a prospective pneumonia study. Am J Med (1982) 1.34
Reasons for non-treatment of hepatitis C in veterans in care. J Viral Hepat (2005) 1.32
Nasal carriage of and infection with Staphylococcus aureus in HIV-infected patients. Ann Intern Med (1999) 1.32
Intraocular candidiasis in patients with candidemia. Clinical implications derived from a prospective multicenter study. Ophthalmology (1994) 1.32